O'Shaughnessy Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$450K Sell
128,243
-162,035
-56% -$664K ﹤0.01% 1578
2025
Q4
$978K Buy
+290,278
New +$754K 0.01% 1157
2024
Q2
Sell
-14,438
Closed -$126K 2007
2024
Q1
$126K Sell
14,438
-7,803
-35% -$94.7K ﹤0.01% 1565
2023
Q4
$254K Sell
22,241
-13,397
-38% -$133K ﹤0.01% 1289
2023
Q3
$343K Sell
35,638
-97,463
-73% -$955K 0.01% 1055
2023
Q2
$1.42M Buy
133,101
+509
+0.4% +$5.47K 0.02% 553
2023
Q1
$1.39M Buy
132,592
+5,154
+4% +$57.7K 0.02% 550
2022
Q4
$1.58M Buy
127,438
+32,162
+34% +$365K 0.03% 476
2022
Q3
$987K Buy
95,276
+71,426
+299% +$810K 0.02% 560
2022
Q2
$275K Buy
23,850
+4,178
+21% +$49.2K 0.01% 903
2022
Q1
$247K Sell
19,672
-180
-0.9% -$2.06K ﹤0.01% 981
2021
Q4
$231K Buy
19,852
+2,195
+12% +$26.9K ﹤0.01% 1003
2021
Q3
$231K Buy
17,657
+4,368
+33% +$56.5K ﹤0.01% 974
2021
Q2
$171K Hold
13,289
﹤0.01% 1103
2021
Q1
$148K Hold
13,289
﹤0.01% 1048
2020
Q4
$151K Buy
13,289
+2,509
+23% +$27.5K ﹤0.01% 937
2020
Q3
$97K Hold
10,780
﹤0.01% 910
2020
Q2
$111K Buy
+10,780
New +$110K ﹤0.01% 812

Other funds holding IRWD

O'Shaughnessy Asset Management's IRWD Position: Q1 2026 in Review

O'Shaughnessy Asset Management reduced its Ironwood Pharmaceuticals (IRWD) stake by 56% in Q1 2026, selling an estimated $664K and leaving 128,243 shares worth $450K. The position accounts for ﹤0.01% of the portfolio, ranked #1578.

O'Shaughnessy Asset Management first reported a position in IRWD in Q2 2020 and has held it in 18 quarters since. The position peaked at $1.58M in Q4 2022. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • O'Shaughnessy Asset Management held 128,243 shares of Ironwood Pharmaceuticals worth $450K as of Q1 2026.
  • O'Shaughnessy Asset Management sold 162,035 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $664K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of O'Shaughnessy Asset Management's portfolio in Q1 2026, its #1578 holding.
  • O'Shaughnessy Asset Management first reported a position in Ironwood Pharmaceuticals in Q2 2020 and has held it in 18 quarters since.
  • O'Shaughnessy Asset Management's Ironwood Pharmaceuticals position peaked at $1.58M in Q4 2022.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q1 2026, filed 13 May 2026.